Header

UZH-Logo

Maintenance Infos

Synthesis and Preliminary evaluation of a 2-oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor


Mu, Linjing; Slavik, Roger; Müller, Adrienne; Popaj, Kasim; Cermak, Stjepko; Weber, Markus; Schibli, Roger; Krämer, Stefanie D; Ametamey, Simon M (2014). Synthesis and Preliminary evaluation of a 2-oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor. Pharmaceuticals, 7(3):339-352.

Abstract

Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and therefore plays an important role in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis, amyotrophic lateral sclerosis and Alzheimer's disease. The CB2 receptor is therefore considered as a very promising target for therapeutic approaches as well as for imaging. A promising 2-oxoquinoline derivative designated KP23 was synthesized and radiolabeled and its potential as a ligand for PET imaging the CB2 receptor was evaluated. [11C]KP23 was obtained in 10%-25% radiochemical yield (decay corrected) and 99% radiochemical purity. It showed high stability in phosphate buffer, rat and mouse plasma. In vitro autoradiography of rat and mouse spleen slices, as spleen expresses a high physiological expression of CB2 receptors, demonstrated that [11C]KP23 exhibits specific binding towards CB2. High spleen uptake of [11C]KP23 was observed in dynamic in vivo PET studies with Wistar rats. In conclusion, [11C]KP23 showed promising in vitro and in vivo characteristics. Further evaluation with diseased animal model which has higher CB2 expression levels in the brain is warranted.

Abstract

Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and therefore plays an important role in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis, amyotrophic lateral sclerosis and Alzheimer's disease. The CB2 receptor is therefore considered as a very promising target for therapeutic approaches as well as for imaging. A promising 2-oxoquinoline derivative designated KP23 was synthesized and radiolabeled and its potential as a ligand for PET imaging the CB2 receptor was evaluated. [11C]KP23 was obtained in 10%-25% radiochemical yield (decay corrected) and 99% radiochemical purity. It showed high stability in phosphate buffer, rat and mouse plasma. In vitro autoradiography of rat and mouse spleen slices, as spleen expresses a high physiological expression of CB2 receptors, demonstrated that [11C]KP23 exhibits specific binding towards CB2. High spleen uptake of [11C]KP23 was observed in dynamic in vivo PET studies with Wistar rats. In conclusion, [11C]KP23 showed promising in vitro and in vivo characteristics. Further evaluation with diseased animal model which has higher CB2 expression levels in the brain is warranted.

Statistics

Citations

Altmetrics

Downloads

25 downloads since deposited on 20 Feb 2015
8 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Nuclear Medicine
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2014
Deposited On:20 Feb 2015 11:35
Last Modified:08 Dec 2017 12:07
Publisher:MDPI Publishing
ISSN:1424-8247
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.3390/ph7030339
PubMed ID:24662272

Download

Download PDF  'Synthesis and Preliminary evaluation of a 2-oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor'.
Preview
Content: Published Version
Filetype: PDF
Size: 888kB
View at publisher